Author name: Leonardo Arias

Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on health tech — especially artificial intelligence, according to a report by Silicon Valley Bank.

CEO Rob Davis referred to the cost reduction program as a ‘reallocation’ rather than a cut, with the savings to be reinvested to support up to 20 new product launches.

Pascal Soriot’s comments came during AstraZeneca’s Q2 earnings call in regard to President Donald Trump’s newly announced European pharma tariffs. The company also announced estimate-beating earnings, with its cancer portfolio driving earnings despite clinical roadblocks.

Six weeks after HHS Secretary RFK Jr. cited unexplained conflicts of interest in dismissing all 17 members of the CDC’s vaccine advisory committee, Democrats are asking for details.

In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its semaglutide franchise in the U.S.—and named current international operations head Maziar Mike Doustdar as its new president and CEO.

Los hallazgos de un nuevo estudio arqueológico ponen en tela de juicio las suposiciones sostenidas durante mucho tiempo de que la agricultura intensiva en Norteamérica se limitaba a sociedades centralizadas o a entornos favorables.   El estudio lo ha realizado un equipo integrad …

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus erythematosus and plaque psoriasis, and $300 million in funds from Bain Capital.

In a post on X, Health Secretary Robert F. Kennedy Jr. alleged that the Vaccine Injury Compensation Program has “devolved into a morass of inefficiency, favoritism, and outright corruption.”

While some analysts forecast the tariffs could mean billions in additional industry expenditure, others expect the overall impact to be “manageable.”

Health plans should directly contract with drug manufacturers to provide medications at transparent and affordable prices, argues Kathy Chang, head of trade relations at Blue Shield of California.